Pathology assessment with impedance measurements using convergent bioelectric lead fields

• US 7,447,543 B2
• Filed: 02/15/2005
• Issued: 11/04/2008
• Est. Priority Date: 02/15/2005
• Status: Active Grant

• Current Assignee: Regents of The University of Minnesota (University of Minnesota)
• Original Assignee: Regents of The University of Minnesota (University of Minnesota)
• Inventors: Belalcazar, Andres, Patterson, Robert
• Primary Examiner(s): SCHAETZLE, KENNEDY
• Application Number:
  US11/058,123
• Publication Number:
  US 20060184060A1
• Time in Patent Office: 1,358 Days
• Field of Search: 600/547, 600/301, 600/506, 600/483, 600/484
• US Class Current: 600/547
• CPC Class Codes: A61B 5/0537 Measuring body composition by impedance, e.g. tissue hydration or fat content
• CPC Class Codes: A61B 5/416 the spleen
• CPC Class Codes: A61B 5/4519 Muscles A61B5/389, A61B5/224 take precedence

Abstract

A method and apparatus for measuring impedance for pathology assessment in a living being using convergent bioelectric lead fields is disclosed, including injecting a current between first and second electrodes implanted in a body of a living being, where the first and second electrodes define a first electric lead field oriented between the first and second electrodes. A potential difference is measured between third and fourth electrodes implanted in the body, where the potential difference results from the current injected between the first and second electrodes. The third and fourth electrodes define a second electric lead field oriented between the third and fourth electrodes. The first and second electric lead fields converge near an assessment site within the body, but are substantially separated otherwise. An impedance value is calculated based on the potential difference and the current injection, and is used to assess a pathology near the assessment site.

Claims

1. A method of measuring impedance for pathology assessment in a living being, the method comprising:

injecting a current between first and second electrodes implanted in a body of a living being, the first and second electrodes defining a first electric lead field in the body, the first electric lead field oriented between the first and second electrodes;

measuring a potential difference between third and fourth electrodes implanted in the body, the potential difference resulting from the current injected between the first and second electrodes, the third and fourth electrodes defining a second electric lead field in the body, the second electric lead field oriented between the third and fourth electrodes, wherein the first and second electric lead fields converge near an assessment site within the body, but are substantially separated otherwise; and

calculating an impedance value based on the potential difference and the current injection, and using the impedance value to assess a pathology near the assessment site.

2. The method of claim 1, wherein the assessment site is not within a heart chamber.

3. The method of claim 2, wherein the assessment site is a left lung and the pathology is pulmonary edema.

4. The method of claim 2, wherein the assessment site is a left ventricular wall of a heart and the pathology is myocardial ischemia.

5. The method of claim 2, wherein the assessment site is a left ventricular wall of a heart and the pathology is left ventricular hypertrophy.

6. The method of claim 1, wherein the second and fourth electrodes are positioned near a left ventricle of a heart, the first electrode is positioned in a pectoral region, and the third electrode is positioned in a right atrium of the heart.

7. The method of claim 1, wherein the second and fourth electrodes are positioned near a left ventricle of a heart, the first electrode is positioned in a pectoral region, and the third electrode is positioned near a brachiocepahlic vein.

8. The method of claim 1, wherein the second and fourth electrodes are positioned near a left ventricle of a heart, the first electrode is positioned in a pectoral region, and the third electrode is positioned in a superior vena cava.

9. The method of claim 1, wherein the second and fourth electrodes are positioned near a left ventricle of a heart, the first electrode is positioned in a right ventricle of the heart, and the third electrode is positioned in a right atrium of the heart.

10. The method of claim 1, wherein the second and fourth electrodes are positioned near a left ventricle of a heart, the first electrode is positioned in a right ventricle of the heart, and the third electrode is positioned in a superior vena cava.

11. The method of claim 1, wherein the second and fourth electrodes are separated by about fifteen millimeters.

12. The method of claim 1, wherein the second and fourth electrodes are separated by about twenty-five millimeters.

13. The method of claim 1, wherein the first and third electrodes are separated by at least about four centimeters.

14. The method of claim 1, wherein the first and third electrodes are separated by at least about ten centimeters.

15. The method of claim 1, further comprising triggering an alarm in response to the pathology assessment.

16. The method of claim 1, further comprising storing the impedance value for later reference.

17. The method of claim 1 further comprising transmitting the impedance value to a monitoring station.

18. The method of claim 1 further comprising injecting a second current between the first and second electrodes, measuring a second potential difference between the third and fourth electrodes, calculating a second impedance value based on the second potential difference and the second current injection, and using the first and second impedance values to assess the pathology near the assessment site, wherein the first and second currents are alternating currents of different frequencies, and wherein the second potential difference results from the second current injected between the first and second electrodes.

19. The method of claim 18, wherein the first current has a frequency of about one kilohertz and the second current has a frequency of about five hundred kilohertz.

20. The method of claim 18 further comprising classifying the pathology based on the first and second impedance values.

21. The method of claim 18, wherein impedance effects of two or more pathologies are discriminated based on the first and second impedance values.

22. The method of claim 1, wherein the current is a composite signal comprising two or more frequencies.

23. The method of claim 22 further comprising extracting frequency components from the potential difference, the frequency components corresponding to the two or more frequencies, wherein the potential difference is a voltage signal.

24. The method of claim 1 further comprising comparing the impedance value to a threshold value.

25. An implantable medical device for measuring impedance for pathology assessment in a living being, comprising:

a pulse generator to inject a current between first and second electrodes implanted in a body of a living being, the first and second electrodes defining a first electric lead field in the body, the first electric lead field oriented between the first and second electrodes;

a voltage measurement circuit to measure a potential difference between third and fourth electrodes implanted in the body, the potential difference resulting from the current injected between the first and second electrodes, the third and fourth electrodes defining a second electric lead field in the body, the second electric lead field oriented between the third and fourth electrodes, wherein the first and second electric lead fields converge near an assessment site within the body, but are substantially separated otherwise; and

a processing unit to calculate an impedance value based on the potential difference and the current injection, and to use the impedance value to assess a pathology near the assessment site.

26. The implantable medical device of claim 25, wherein the assessment site is not within a heart chamber.

27. The implantable medical device of claim 26, wherein the assessment site is a left lung and the pathology is pulmonary edema.

28. The implantable medical device of claim 26, wherein the assessment site is a left ventricular wall of a heart and the pathology is myocardial ischemia.

29. The implantable medical device of claim 25, wherein the second and fourth electrodes are separated by about fifteen millimeters.

30. The implantable medical device of claim 25, wherein the second and fourth electrodes are separated by about twenty-five millimeters.

31. The implantable medical device of claim 25, wherein the first and third electrodes are separated by at least about four centimeters.

32. The implantable medical device of claim 25, wherein the first and third electrodes are separated by at least about ten centimeters.

33. The implantable medical device of claim 25, wherein the processing unit triggers an alarm in response to the pathology assessment.

34. The implantable medical device of claim 25 further comprising a transceiver to transmit the impedance value to a monitoring station.

35. The implantable medical device of claim 25, wherein the pulse generator injects a second current between the first and second electrodes, measures a second potential difference between the third and fourth electrodes, calculates a second impedance value based on the second potential difference and the second current injection, and uses the first and second impedance values to assess the pathology near the assessment site, wherein the first and second currents are alternating currents of different frequencies, and wherein the second potential difference results from the second current injected between the first and second electrodes.

36. A method of measuring impedance phase angle for pathology assessment in a living being, the method comprising:

injecting a current between first and second electrodes implanted in a body of a living being, the first and second electrodes defining a first electric lead field in the body, the first electric lead field oriented between the first and second electrodes;

measuring a potential difference between third and fourth electrodes implanted in the body, the potential difference resulting from the current injected between the first and second electrodes, the third and fourth electrodes defining a second electric lead field in the body, the second electric lead field oriented between the third and fourth electrodes, wherein the first and second electric lead fields converge near an assessment site within the body, but are substantially separated otherwise; and

calculating an impedance phase angle value based on the potential difference and the current injection, and using the impedance phase angle value to assess a pathology near the assessment site.

37. The method of claim 36 further comprising injecting a second current between the first and second electrodes, measuring a second potential difference between the third and fourth electrodes, calculating a second impedance phase angle value based on the second potential difference and the second current injection, and using the first and second impedance phase angle values to assess the pathology near the assessment site, wherein the first and second currents are alternating currents of different frequencies, and wherein the second potential difference results from the second current injected between the first and second electrodes.

38. The method of claim 37 further comprising classifying the pathology based on the first and second impedance phase angle values.

39. The method of claim 37, wherein impedance effects of two or more pathologies are discriminated based on the first and second impedance phase angle values.